151 related articles for article (PubMed ID: 18071066)
1. p53 Nuclear accumulation and Bcl-2 expression in contiguous adenomatous components of colorectal adenocarcinomas predict aggressive tumor behavior.
Shanmugam C; Katkoori VR; Jhala NC; Grizzle WE; Siegal GP; Manne U
J Histochem Cytochem; 2008 Mar; 56(3):305-12. PubMed ID: 18071066
[TBL] [Abstract][Full Text] [Related]
2. Combined role of tumor angiogenesis, bcl-2, and p53 expression in the prognosis of patients with colorectal carcinoma.
Giatromanolaki A; Stathopoulos GP; Tsiompanou E; Papadimitriou C; Georgoulias V; Gatter KC; Harris AL; Koukourakis MI
Cancer; 1999 Oct; 86(8):1421-30. PubMed ID: 10526268
[TBL] [Abstract][Full Text] [Related]
3. Recurrence and survival predictive value of phenotypic expression of Bcl-2 varies with tumor stage of colorectal adenocarcinoma.
Chatla C; Jhala NC; Katkoori VR; Alexander D; Meleth S; Grizzle WE; Manne U
Cancer Biomark; 2005; 1(4-5):241-50. PubMed ID: 17192048
[TBL] [Abstract][Full Text] [Related]
4. Prognostic evaluation of CD44 expression in correlation with bcl-2 and p53 in colorectal cancer.
Zavrides HN; Zizi-Sermpetzoglou A; Panousopoulos D; Athanasas G; Elemenoglou I; Peros G
Folia Histochem Cytobiol; 2005; 43(1):31-6. PubMed ID: 15871560
[TBL] [Abstract][Full Text] [Related]
5. An immunohistochemical study of the simultaneous expression of bcl-2 and p53 oncoproteins in epithelial tumors of the colon and rectum.
Mosnier JF; Perret AG; Vindimian M; Dumollard JM; Balique JG; Perpoint B; Boucheron S
Arch Pathol Lab Med; 1996 Jul; 120(7):654-9. PubMed ID: 8757470
[TBL] [Abstract][Full Text] [Related]
6. Bcl-2 expression in colorectal tumours. Correlation with p53, mdm-2, Rb proteins and proliferation indices.
Goussia AC; Ioachim E; Agnantis NJ; Mahera M; Tsianos EV
Histol Histopathol; 2000 Jul; 15(3):667-72. PubMed ID: 10963109
[TBL] [Abstract][Full Text] [Related]
7. Epithelial neoplasms of the appendix and colorectum: an analysis of cell proliferation, apoptosis, and expression of p53, CD44, bcl-2.
Carr NJ; Emory TS; Sobin LH
Arch Pathol Lab Med; 2002 Jul; 126(7):837-41. PubMed ID: 12088454
[TBL] [Abstract][Full Text] [Related]
8. Racial differences in the prognostic usefulness of MUC1 and MUC2 in colorectal adenocarcinomas.
Manne U; Weiss HL; Grizzle WE
Clin Cancer Res; 2000 Oct; 6(10):4017-25. PubMed ID: 11051251
[TBL] [Abstract][Full Text] [Related]
9. Bax protein expression in colorectal cancer: association with p53, bcl-2 and patterns of relapse.
Giatromanolaki A; Sivridis E; Stathopoulos GP; Fountzilas G; Kalofonos HP; Tsamandas A; Vrettou E; Scopa C; Polychronidis A; Simopoulos K; Koukourakis MI
Anticancer Res; 2001; 21(1A):253-9. PubMed ID: 11299743
[TBL] [Abstract][Full Text] [Related]
10. Bcl-2 expression is associated with improved prognosis in patients with distal colorectal adenocarcinomas.
Manne U; Weiss HL; Grizzle WE
Int J Cancer; 2000 Sep; 89(5):423-30. PubMed ID: 11008204
[TBL] [Abstract][Full Text] [Related]
11. Thymidylate synthase expression, p53, bcl-2, Ki-67 and p27 in colorectal cancer: relationships with tumor recurrence and survival.
Rosati G; Chiacchio R; Reggiardo G; De Sanctis D; Manzione L
Tumour Biol; 2004; 25(5-6):258-63. PubMed ID: 15627889
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical expression of bcl-2 and p53 oncoproteins: correlation with Ki67 proliferation index and prognostic histopathologic parameters in colorectal neoplasia.
Saleh HA; Jackson H; Banerjee M
Appl Immunohistochem Mol Morphol; 2000 Sep; 8(3):175-82. PubMed ID: 10981868
[TBL] [Abstract][Full Text] [Related]
13. Villous tumor of the colon and rectum with special reference to roles of p53 and bcl-2 in adenoma-carcinoma sequence.
Yao T; Kajiwara M; Kouzuki T; Iwashita A; Tsuneyoshi M
Pathol Int; 1999 May; 49(5):374-82. PubMed ID: 10417679
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of Bcl-2 expression and p53 nuclear accumulation in colorectal adenocarcinoma.
Manne U; Myers RB; Moron C; Poczatek RB; Dillard S; Weiss H; Brown D; Srivastava S; Grizzle WE
Int J Cancer; 1997 Jun; 74(3):346-58. PubMed ID: 9221816
[TBL] [Abstract][Full Text] [Related]
15. The role of p53, p21WAF1/C1PI, and bcl-2 in radioresistant colorectal carcinoma.
Palazzo JP; Kafka NJ; Grasso L; Chakrani F; Hanau C; Cuesta KH; Mercer WE
Hum Pathol; 1997 Oct; 28(10):1189-95. PubMed ID: 9343326
[TBL] [Abstract][Full Text] [Related]
16. The correlation between the immunostains for p53 and Ki67 with bcl-2 expression and classical prognostic factors in colorectal carcinomas.
Gurzu S; Jung J; Mezei T; Pávai Z
Rom J Morphol Embryol; 2007; 48(2):95-9. PubMed ID: 17641794
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical expression of bcl-2 in UICC stage I and III colorectal carcinoma patients: correlation with c-erbB-2, p53, ki-67, CD44, laminin and collagen IV in evaluating prognostic significance.
Zavrides H; Zizi-Sermpetzoglou A; Elemenoglou I; Papatheofanis I; Peros G; Athanasas G; Panousopoulos D
Pol J Pathol; 2006; 57(3):149-59. PubMed ID: 17219742
[TBL] [Abstract][Full Text] [Related]
18. Differential expression of Bcl-2, Bcl-XL and p53 in colorectal cancer.
Han HS; Park YM; Hwang TS
J Gastroenterol Hepatol; 2006 Jul; 21(7):1108-14. PubMed ID: 16824061
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of multiple bio-pathological factors in colorectal adenocarcinomas: independent prognostic role of p53 and bcl-2.
Buglioni S; D'Agnano I; Cosimelli M; Vasselli S; D'Angelo C; Tedesco M; Zupi G; Mottolese M
Int J Cancer; 1999 Dec; 84(6):545-52. PubMed ID: 10567896
[TBL] [Abstract][Full Text] [Related]
20. bcl-2 and p53 expression in resectable pancreatic adenocarcinomas: association with clinical outcome.
Sinicrope FA; Evans DB; Leach SD; Cleary KR; Fenoglio CJ; Lee JJ; Abbruzzese JL
Clin Cancer Res; 1996 Dec; 2(12):2015-22. PubMed ID: 9816161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
